After administration of these two oncolytic adenoviruses in the nude mouse melanoma transplant tumor model, vascular endothelial growth factor (VEGF) and transforming growth factor β were inhibited, which led to anti-angiogenic activity. The gene discussed is VEGFA; the disease is melanoma.